Global Heart Failure Market to Reach Multi‑Billion by 2035 – BIS Research

What Is the Market Outlook? 

The heart failure market is evolving through an expansion phase toward maturity. Adoption of personalized medicine, including genomic and biomarker-driven approaches, is increasing. Simultaneously, digital health tools like wearables and remote monitoring are enabling proactive management, aiming to reduce hospital readmissions and improve patient quality of life. 

How Fast Is the Market Growing? 

The heart failure market is rapidly expanding, driven by rising disease prevalence, innovative drug development, and advanced monitoring technologies. Growing healthcare access and evolving treatment guidelines are further accelerating adoption, positioning the market for sustained momentum across therapies and geographies. 

How Will This Report Help You? 

Planning to Enter the Market? 

• Gain macro‑ and micro‑level epidemiological trends, regulatory landscapes across regions (U.S., EU, APAC), and clinical adoption drivers. 

Analyzing the Competitive Landscape? 

• Benchmark major players (AstraZeneca, Bayer AG, Bristol Myers Squibb, Cytokinetics, Eli Lilly) based on product pipelines, device portfolios, and clinical trial activity. 

Seeking R&D Insights? 

• Uncover the impact of SGLT2 and neprilysin inhibitors, implantable defibrillators, ventricular assist devices, and remote patient monitoring systems. 

Interested in Regional Market Trends? 

• Get region‑wise breakdowns: North America’s dominance, Europe’s therapeutic uptake, Asia‑Pacific growth, plus segmented forecasts. 

Explore the Full TOC and Download Report Sample     

What Technologies Are Transforming the Market? 

• Novel Drug Classes: SGLT2 inhibitors, neprilysin inhibitors, ARBs – improving outcomes. 
• Cardiac Devices: ICDs, pacemakers, ventricular assist devices aiding symptom control and survival. 
• Digital Health & Remote Monitoring: Wearables, telemedicine, and digital platforms enabling continuous patient oversight. 
• Personalised Medicine: Genomic testing, biomarkers guiding tailored treatment pathways. 

What’s Driving Demand and What Are the Barriers?

Drivers: 

• Growing heart failure burden from hypertension, diabetes, coronary disease 
• Aging demographics increasing prevalence  
• Technological progress in drugs and devices 
• Rising awareness of proactive patient management strategies 

Restraints: 

• High costs: advanced drugs, devices, hospital care  
• Complex multifactorial disease requiring personalized approaches 
• Underserved markets with limited access and late diagnosis  

Opportunities: 

• Expand in emerging markets (Asia‑Pacific, Latin America) 
• Develop solutions for HFpEF—a currently underserved segment 
• Leverage remote monitoring for rural and low‑resource regions 

How Is the Market Segmented? 

By Drug Class 

• ACE Inhibitors 

• Beta Blockers 

• Diuretics 

• Angiotensin 2 Receptor Antagonists 

• Aldosterone Antagonists 

• Others 

By Region 

• North America 

• Europe 

• Asia-Pacific 

• Rest-of-the-World 

Who Are the Key Players in the Market? 

• Novartis AG 

• Pfizer Inc. 

• Bayer AG 

Strategic Moves Shaping the Future: 

1.Mergers & Acquisitions: e.g., J&J acquiring V-Wave for approx. US$1.7 billion—aiming to expand heart failure device portfolio. 

2. Clinical Innovation: Cytokinetics pushing novel therapies like aficamten—next-generation agents in development. 

3.Digital Integration: Combining devices with wearables and AI-driven platforms to optimize monitoring and adherence. 

Download the Complete TOC now! 

Case Study: J&J’s Acquisition of V‑Wave 

Johnson & Johnson’s planned $600 million upfront (up to $1.7 billion total) acquisition of V‑Wave Ltd brings a catheter-delivered implant designed for HFrEF patients, aiming to reduce left atrial pressure, potentially cutting cardiovascular events and readmissions. The device has FDA Breakthrough Designation and targets an 800,000-patient annual U.S. market. This move underscores how major firms are investing in device-led solutions. 

Schedule a Call with Industry Experts 

Related Reports from BIS Research 

Chronic Heart Failure Market 

Cardiac Ablation Market 

Cardiovascular Image Fusion Software Market 

About BIS Research 

BIS Research is a global B2B market intelligence and advisory firm focusing on deep technology and related emerging trends, which can disrupt the market dynamics in the near future. We publish over 200 market intelligence studies annually, focusing on several deep technology verticals.   

Our strategic market analysis emphasizes market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision-making for senior management.    

BIS Research offers syndicate and custom studies and expert consultations to firms, providing them with specific and actionable insights on novel technology markets, business models, and competitive landscapes.   

Contact 

Head of Marketing  

Email: media@bisresearch.com    

BIS Research Inc.   

39111 PASEO PADRE PKWY STE 313,   

FREMONT, CA 94538-1686  

Visit our Blog @https://bisresearch.com/insights   

Get Expert Insights @https://community.insightmonk.com    

Connect with us on LinkedIn @ https://www.linkedin.com/company/bis-research    

Connect with us on Twitter@ https://twitter.com/BISResearch